We are live on ! Find out more
EVH icon

Evolent Health
EVH

Fund managers haven’t disclosed any holdings of EVH yet.

EVH Hedge Fund Activity: Q1 2026 in Review

191 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2026, worth a combined $252M — down 48% from $482M a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of EVH and 42 opened new positions — a net loss of 19 holders — while 59 trimmed existing stakes and 58 added.

The largest buyer was Eventide Asset Management, opening a new position worth an estimated $8.08M. The largest seller was JP Morgan Chase, cutting an estimated $8.11M.

  • 191 institutional investors held Evolent Health (EVH) as of Q1 2026, down from 215 in Q4 2025.
  • Funds reported $252M of Evolent Health stock for Q1 2026, down 48% quarter-over-quarter.
  • 42 funds opened new Evolent Health positions in Q1 2026 and 61 closed out, a net change of -19 holders.
  • The largest Evolent Health buyer in Q1 2026 was Eventide Asset Management, an estimated $8.08M added.
  • The largest Evolent Health seller in Q1 2026 was JP Morgan Chase, an estimated $8.11M sold.

Based on aggregated 13F filings for Q1 2026.